Article
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
10 Mar 2021
Abstract excerpt
BACKGROUND: Genomic analysis is essential for risk stratification in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Whole-genome sequencing is a potential replacement for conventional cytogenetic and sequencing approaches, but its accuracy, feasibility, and clinical utility have not been demonstrated. METHODS: We used a streamlined whole-genome sequencing approach to obtain genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
